Travatan and Ditropan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Travatan (travoprost) and Ditropan (oxybutynin chloride). Common drug interactions include exercise tolerance decreased among females and basal cell carcinoma among males.

The phase IV clinical study analyzes what interactions people have when they take Travatan and Ditropan. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Travatan?

Travatan has active ingredients of travoprost. It is often used in glaucoma. eHealthMe is studying from 13,103 Travatan users. Check the latest studies of Travatan.

What is Ditropan?

Ditropan has active ingredients of oxybutynin chloride. It is often used in urge incontinence. eHealthMe is studying from 11,799 Ditropan users. Check the latest studies of Ditropan.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

18 people who take Travatan and Ditropan together, and have interactions are studied.

Travatan and Ditropan drug interactions.

What are the common drug interactions of Travatan and Ditropan, by gender? *:

female:

  1. Exercise tolerance decreased
  2. Fall
  3. Fungal infection
  4. Glomerular filtration rate decreased
  5. Haemorrhage (bleeding)
  6. Anxiety
  7. Asthenia (weakness)
  8. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  9. Blood cholesterol increased
  10. Bradycardia (abnormally slow heart action)

male:

  1. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  2. Coagulopathy (blood's ability to clot is impaired)
  3. Skin ulcer
  4. Subdural haematoma (blood collects between the skull and the surface of the brain)
  5. Tuberculin test positive
  6. Colitis ischaemic (due to infection of intestine impaired blood supply to colon)
  7. Fatigue (feeling of tiredness)
  8. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  9. Hallucination, visual (seeing things that aren't there)
  10. Hepatic enzyme increased

What are the common drug interactions of Travatan and Ditropan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Fatigue (feeling of tiredness)
  2. Anxiety
  3. Diarrhoea
  4. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  5. Dyspnoea (difficult or laboured respiration)
  6. General physical health deterioration (weak health status)
  7. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  8. Hypotension (abnormally low blood pressure)
  9. Hypovolaemia (a decreased volume of circulating blood in the body)
  10. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)

What are the existing conditions these people have? *

  1. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 22.22%
  2. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 16.67%
  3. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 11.11%
  4. Pain: 2 people, 11.11%
  5. Stress And Anxiety: 1 person, 5.56%
  6. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 5.56%
  7. Psoriasis (immune-mediated disease that affects the skin): 1 person, 5.56%
  8. Prostate Cancer Metastatic: 1 person, 5.56%
  9. Torticollis (a twisted neck in which the head is tipped to one side, while the chin is turned to the other): 1 person, 5.56%
  10. Tachyarrhythmia (disturbance of the heart rhythm in which the heart rate is abnormally increased): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Travatan and Ditropan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Travatan and Ditropan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Travatan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ditropan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Travatan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ditropan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on travoprost and oxybutynin chloride (the active ingredients of Travatan and Ditropan, respectively), and Travatan and Ditropan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: